Medicament for treating bronchitis

A bronchitis and drug technology, applied in the field of drugs for the treatment of bronchitis, can solve problems such as difficult to cure inflammatory diseases, failure of antibiotic drugs, high risk of drug resistance, etc., to achieve convenient medication, short treatment cycle, and quick onset Effect

Inactive Publication Date: 2015-08-19
孟智琴
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Traditional treatment methods use antibiotics, which have the advantage of fast anti-inflammatory effects, but scientists from all over the world have confirmed that long-term use of antibiotics will produce more resistant and more harmful bacteria, which will eventually lead to a lot of antibiotics. Ineffective, inflammatory diseases are increasingly difficult to cure
In recent years, some pure traditional Chinese medicine drugs have appeared, but these existing drugs can only temporarily control the symptoms, and there are still problems that cannot be completely cured.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] A medicine for treating bronchitis, comprising the following raw materials in parts by weight: licorice extract powder: 8 g, chlorpheniramine maleate: 0.1 g, ketotifen fumarate: 0.068 g, prednisone acetate: 0.18 g, aminophylline: 2.5 g, oxytetracycline: 6.5 g, dioxpromazine hydrochloride: 0.2 g and Chuan Fritillaria: 25 g.

[0053] The above-mentioned medicine for treating bronchitis, the preparation method comprises the following steps:

[0054] (1) Take appropriate amount of Compound Licorice Tablets, Chlorpheniramine Maleate Tablets, Ketotifen Fumarate Tablets, Prednisone Acetate Tablets, Aminophylline Tablets, Oxytetracycline Tablets, Dioxpromazine Hydrochloride Tablets, Grinding and pulverizing into powder, passing through 80-120 mesh sieve respectively; drying and pulverizing into powder, passing through 80-120 mesh sieve;

[0055] (2) Accurately weigh the raw material powders of the above-mentioned parts by weight;

[0056] (3) Mix the raw materials in step (2)...

Embodiment 2

[0058] A medicine for treating bronchitis, comprising the following raw materials in parts by weight: licorice extract powder: 9 g, chlorpheniramine maleate: 0.14 g, ketotifen fumarate: 0.07 g, prednisone acetate: 0.21 g, aminophylline: 2.8 g, oxytetracycline: 7.1 g, dioxpromazine hydrochloride: 0.25 g and Chuan Fritillaria: 27 g.

[0059] The preparation method of the above-mentioned medicine for treating bronchitis is as in Example 1.

Embodiment 3

[0061] A medicine for treating bronchitis, comprising the following raw materials in parts by weight: licorice extract powder: 10 g, chlorpheniramine maleate: 0.24 g, ketotifen fumarate: 0.08 g, prednisone acetate: 0.25 g, aminophylline: 3.2 g, oxytetracycline: 7.5 g, dioxpromazine hydrochloride: 0.3 g and Chuan Fritillaria: 30 g.

[0062] The preparation method of the above-mentioned medicine for treating bronchitis is as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicament for treating bronchitis. The medicament comprises the following raw materials in parts by weight: 8 to 12 parts of liquoric root extract powder, 0.1 to 0.3 parts of chlorpheniramine maleate, 0.068 to 0.1 parts of ketotifen fumarate, 0.18 to 0.32 parts of prednisone acetate, 2.5 to 4.1 parts of aminophylline, 6.5 to 8.6 parts of oxytetracycline, 0.2 to 0.4 parts of dioxopromethazine hydrochloride and 25 to 35 parts of unibract fritillary bulb. The medicament for treating bronchitis has the advantages of reasonable compatibility, convenience in taking, prevention of relapse, short treatment period, quick response, achievement of remarkable effect on the administration day, curative rate of up to 89.5 percent, total effective rate of up to 99 percent, simple preparation method, low cost and particularly remarkable effects on emphysema and lasting chronic bronchitis.

Description

Technical field [0001] The present invention is a pharmaceutical product technology field, which involves a drug that treats bronchitis. Background technique [0002] Bronchitis refers to chronic non -specific inflammation of bronchial, bronchial mucosa and its surrounding tissues.The onset of acute bronchitis is faster. It starts to cough. In the future, cough, sticky sputum or purulent sputum, often accompanied by stern bloating or pain, fever and other systemic symptoms, which are mostly improved within 3 to 5 days.It was restored in 2 to 3 weeks.Chronic bronchitis takes a long -term, repeated cough as prominent symptoms, accompanied by sputum, sputum symptoms related to infection, light and severe, and can also be accompanied by asthma and delay.The severe destruction of these diseases with the health of the patient. [0003] The traditional treatment method uses antibiotic drugs. Antibiotic drugs have the advantages of fast anti -inflammatory effects, but after confirmation ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8966A61P11/00A61K31/4402A61K31/65A61K31/573
Inventor 孟智琴
Owner 孟智琴
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products